| 标题 |
FRI-156 DR10624, a novel FGF21R/GCGR/GLP-1R triple agonist, significantly reduced liver fat and improved hepatic and metabolic biomarkers in a phase 2 study of patients with severe hypertriglyceridemia |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Hepatology 作者:Yongliang Fang; Y. Fan; Long Zhang; Yan Zhang; Chaonan Zhu; et al 出版日期:2026-05-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)